Press Releases


IXICO's Response to Novel Coronavirus (COVID-19) - Update

20 March 2020: IXICO Response to Novel Coronavirus (COVID-19) - Update Dear Valued Client and Partners Earlier this week the UK government updated its guidance in response to the COVID-19 pandemic (as of 16 March), to escalate social distancing measures and minimise the need for non-essential travel.

Read more

Webinar Launch: Optimization of Tau PET Imaging for Alzheimer’s Clinical Development

IXICO will be hosting a webinar entitled 'Optimization of Tau PET Imaging for Alzheimer’s Clinical Development' on Friday 24th April at 10am EDT (NA) / 3pm BST (UK) / 4pm CEST (EU-Central), with our guest speaker Victor L. Villemagne from The University of Melbourne.

Read more

IXICO's Response to Novel Coronavirus (COVID-19)

It is not possible to predict the spread of COVID-19, nor the actions that may be taken by national governments to contain the spread of disease.

Read more

IXICO announces an expanded contract for its imaging services with Vaccinex

Supports Vaccinex's diversification into clinical development of pepinemab for Alzheimer's disease We are delighted to announce an award of a contract to provide imaging services for Vaccinex Inc. 's planned Phase Ib/IIa trial of pepinemab, a potential treatment of Alzheimer's disease (AD).

Read more

IXICO to present AI segmentation research at Huntington's Disease Therapeutics Conference

We will be presenting a scientific poster on enhancing imaging analysis accuracy for Huntington's Disease (HD) by comparing two types of Artificial Intelligence (AI) techniques at the CHDI Foundation 15th Annual 2020 Huntington's Disease Therapeutics Conference held from 24 - 27 February, 2020 in Palm Springs, California, USA.

Read more

IXICO's CEO Giulio Cerroni to present at Shares, Cenkos Growth & Innovation Forum

Our CEO, Giulio Cerroni will be presenting at next week's Growth & Innovation Forum, taking place at the Business Design Centre in London N1 on Tuesday 11th February. Giulio will be presenting in the Flower Room at 12. 15.

Read more

IXICO supports the Alzheimer's Disease Neuroimaging Initiative

IXICO today announced funding support for the Alzheimer's Disease Neuroimaging Initiative (ADNI), and two of their scientists will join the ADNI-Private Partner Scientific Board (PPSB). Watch our Chief Product Officer, Alison Howie's interview with proactive to learn more about IXICO's role within the ADNI partnership.

Read more

Alison Howie, IXICO's Chief Product Officer to participate in AI tech panel at the 6th LSX World Congress

We are delighted to announce that our Chief Product Officer, Alison Howie will be participating in next week's LSX World Congress, taking place in London on 4-5 February. Alison will be participating in the keynote panel discussion entitled 'Realising AI’s potential in life sciences and healthcare' on Wednesday 5th February at 15.

Read more

1-8 of 21 results